Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders
Heart Rhythm SocietyPublished: May 8, 2023
- Top 10 Take-Home Messages
- Duchenne, Becker, and Recessive Limb-girdle Muscular Dystrophies
- Myotonic Dystrophy Types 1 and 2
- Emery-Dreifuss and Limb-girdle Type 1B Muscular Dystrophy
- Facioscapulohumeral Muscular Dystrophy
- Mitochondrial Myopathies Including Friedreich Ataxia
- Shared Decision-making and End-of-life Care
- Tables
- Genetics, cardiovascular complications, and NMDs
- Recessive forms (type 2) of LGMDs associated with CM, listed according to the subtype nomenclature used in this guide
- Clinical scenarios for the management of arrhythmias in DMD, BMD, and recessive LGMD2
- Clinical scenarios for the management of arrhythmias in DM1
- Clinical scenarios for the management of arrhythmias in EDMD and LGMD1B
- Clinical scenarios for management of patients with FA
- NMDs, use of pacemakers and ICDs, shared decision-making principles, and end-of-life care decisions
- Clinical scenarios for end-of-life management in atients with NMD
- Figures
- Rhythm management and CIED in patients with DMD, BMD, or recessive LGMD2 and left ventricular dysfunction
- Rhythm management and CIED implantation in patients with DM1 or DM2 with normal ventricular function and with focus on the risk stratification for the prevention of sudden death
- Rhythm management and CIED implantation in patients with EDMD or LGMD1B
- Rhythm management and CIED implantation in patients with mitochondrial myopathies including FA
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.